tiprankstipranks
TipRanksTop Financial ExpertsInsidersAmy Schulman

Amy Schulman Insider Profile

11 Followers
Amy Schulman, Director at Alnylam Pharma, holds 218.00 shares in Elevance Health (Ticker: ELV), holds 11.96K shares in Alnylam Pharma (Ticker: ALNY), holds 8.55K shares in Fractyl Health, Inc. (Ticker: GUTS). Most recently, Amy Schulman Sold ― shares of Elevance Health on Mar 23, 2026 for an estimated value of $7.47K.
See the Hottest Stocks Based on Insider Trading >
tipranks
Amy Schulman

Amy Schulman
Alnylam Pharma (ALNY)
Director

Ranked #100,037 out of 106,487 Corporate Insiders

Profitable Transactions

0%
0 out of 4 Profitable Transactions

Average Return

-63.30%
Average return per transaction
Time Frame
1 Year
Compare to
No Benchmark
How are Insiders Ranked?

Insider Holdings

$12M
52.09%
32.67%
8.17%
4.85%
2.21% Others
A breakdown of Amy Schulman's holdings
See the Top Stocks by Insiders

Insider Roles

Pfizer
(PFE)
Former Exec. Vice President
Alnylam Pharma
(ALNY)
Director
Cyclerion Therapeutics
(CYCN)
Director
Zoetis
(ZTS)
Director
+5 other positions
Roles that Amy Schulman holds in companies
See the Top Corporate Insiders

Most Profitable Insider Trade

Stock:
SQZ Biotechnologies
(SQZB)
Rating:Informative Buy
Date:Nov 03, 2020 - Nov 03, 2021
Return:-14.60%
The most profitable trade made by Amy Schulman
See the Latest Stocks Traded by Insiders

Amy Schulman's Trading History

Company Name
Last Transaction Date
Insider Position
Last Transaction
Last Transaction Amount
Holding Value
ALNY
Alnylam Pharma
May 12, 2025
Director
Uninformative Buy
―
$3.93M
BUFF
Blue Buffalo
Apr 24, 2018
―
Uninformative Sell
―
$0.00
IRWD
Ironwood Pharma
Apr 03, 2019
Director
Uninformative Sell
―
$120.46K
XFOR
X4 Pharmaceuticals
―
Director
―
―
CYCN
Cyclerion Therapeutics
Apr 10, 2019
Director
Informative Buy
10.02M
$982.12K
SQZB
SQZ Biotechnologies
Dec 23, 2021
Director, Ten Percent Owner
Uninformative Buy
84.82K
$77.33K
GUTS
Fractyl Health, Inc.
Mar 17, 2025
Director
Informative Buy
9.92K
$4.04K
ELV
Elevance Health
Mar 23, 2026
Director
Informative Sell
7.47K
$64.15K
BINDQ
DNIB Unwind, Inc.
―
―
―
$0.00
PFE
Pfizer
May 16, 2013
Former Exec. Vice President
Uninformative Sell
2.06M
$6.26M
ZTS
Zoetis
Feb 08, 2013
Director
Informative Buy
130.00K
$583.15K
List of latest transactions for each holding click on a transaction to see Amy Schulman's performance on stock
See All Insider Trading from Today

You May Also Like

Meet our Smart Portfolio. See what top analysts say about your stocks.Get a breakdown of the different strategies based on detected insider trading activity.Find the best performing Analyst in each sector. Follow them so you never miss a recommendation.

Amy Schulman insider profile FAQ

What is the percentage of profitable transactions made by Amy Schulman?
The percentage of profitable transactions made by Amy Schulman is 0%.
    What is the average return per transaction made by Amy Schulman?
    The average return per transaction made by Amy Schulman is -63.30%.
      What stocks does Amy Schulman hold?
      Amy Schulman holds: ALNY, BUFF, IRWD, XFOR, CYCN, SQZB, GUTS, ELV, BINDQ, PFE, ZTS stocks.
        What was Amy Schulman’s latest transaction?
        Amy Schulman latest transaction was an Informative Sell of $7.47K.
          What was Amy Schulman's most profitable transaction?
          Amy Schulman’s most profitable transaction was an Informative Buy of SQZB stock on November 3, 2020. The return on the trade was -14.60%.
            What is Amy Schulman's role in Alnylam Pharma?
            Amy Schulman's role in Alnylam Pharma is Director.
              How can I follow the stock ratings of top corporate insiders?
              Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.